These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 27376592)
21. Everolimus-eluting bioresorbable scaffold implantation for the treatment of bifurcation lesions - Implications from early clinical experience during daily practice. Wiebe J; Dörr O; Bauer T; Liebetrau C; Boeder N; Möllmann H; Hamm CW; Nef HM Cardiovasc Revasc Med; 2016; 17(5):313-7. PubMed ID: 27085220 [TBL] [Abstract][Full Text] [Related]
22. Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention. Allahwala UK; Cockburn JA; Shaw E; Figtree GA; Hansen PS; Bhindi R EuroIntervention; 2015 Feb; 10(10):1154-9. PubMed ID: 24647105 [TBL] [Abstract][Full Text] [Related]
23. Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions. Fam JM; Ishibashi Y; Felix C; Zhang BC; Diletti R; van Mieghem N; Regar E; van Domburg R; Onuma Y; van Geuns RJ Int J Cardiovasc Imaging; 2017 Dec; 33(12):1863-1871. PubMed ID: 28685314 [TBL] [Abstract][Full Text] [Related]
24. Technology limitations of BRS in bifurcations. Fox J; Hossainy S; Rapoza R; Serruys PW EuroIntervention; 2015; 11 Suppl V():V155-8. PubMed ID: 25983156 [TBL] [Abstract][Full Text] [Related]
25. Percutaneous coronary intervention: balloons, stents and scaffolds. Colleran R; Kastrati A Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189 [TBL] [Abstract][Full Text] [Related]
26. Early U.S. Experience Following FDA Approval of the ABBOTT Vascular Bioresorbable Vascular Scaffold: Optimal Deployment Technique Using High Resolution Coronary Artery Imaging. Rizik DG; Padaliya BB J Interv Cardiol; 2016 Oct; 29(5):546-548. PubMed ID: 27492571 [TBL] [Abstract][Full Text] [Related]
27. Bioresorbable vascular scaffolds in left main coronary artery disease. Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148 [TBL] [Abstract][Full Text] [Related]
28. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries. Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648 [TBL] [Abstract][Full Text] [Related]
29. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure. Tanaka A; Jabbour RJ; Latib A; Colombo A Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460 [TBL] [Abstract][Full Text] [Related]
30. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry. Imori Y; D'Ascenzo F; Gori T; Münzel T; Fabrizio U; Campo G; Cerrato E; Napp LC; Iannaccone M; Ghadri JR; Kazemian E; Binder RK; Jaguszewski M; Csordas A; Capasso P; Biscaglia S; Conrotto F; Varbella F; Garbo R; Gaita F; Erne P; Lüscher TF; Moretti C; Frangieh AH; Templin C Cardiol J; 2016; 23(4):374-83. PubMed ID: 27515481 [TBL] [Abstract][Full Text] [Related]
36. A review of bioresorbable scaffolds: hype or hope? Tan HC; Ananthakrishna R Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135 [TBL] [Abstract][Full Text] [Related]
37. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial. Bennett J; Adriaenssens T; Desmet W; Dubois C Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586 [TBL] [Abstract][Full Text] [Related]
38. Paving the way to a bioresorbable technology: Development of the absorb BRS program. Perkins LE; Kossuth MB; Fox JC; Rapoza RJ Catheter Cardiovasc Interv; 2016 Nov; 88(S1):1-9. PubMed ID: 27797462 [TBL] [Abstract][Full Text] [Related]